SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-067131
Filing Date
2024-08-09
Accepted
2024-08-09 16:05:47
Documents
63
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0210289-10q_hoththerap.htm   iXBRL 10-Q 691839
2 CERTIFICATION ea021028901ex31-1_hoththerap.htm EX-31.1 12003
3 CERTIFICATION ea021028901ex31-2_hoththerap.htm EX-31.2 12010
4 CERTIFICATION ea021028901ex32-1_hoththerap.htm EX-32.1 4084
5 CERTIFICATION ea021028901ex32-2_hoththerap.htm EX-32.2 4115
  Complete submission text file 0001213900-24-067131.txt   4880133

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hoth-20240630.xsd EX-101.SCH 63241
7 XBRL CALCULATION FILE hoth-20240630_cal.xml EX-101.CAL 25391
8 XBRL DEFINITION FILE hoth-20240630_def.xml EX-101.DEF 254032
9 XBRL LABEL FILE hoth-20240630_lab.xml EX-101.LAB 464798
10 XBRL PRESENTATION FILE hoth-20240630_pre.xml EX-101.PRE 249427
66 EXTRACTED XBRL INSTANCE DOCUMENT ea0210289-10q_hoththerap_htm.xml XML 535299
Mailing Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 (646)756-2997
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38803 | Film No.: 241192579
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)